Literature DB >> 23272670

Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea.

Bhavneesh Sharma1, Tomas G Neilan, Raymond Y Kwong, Damien Mandry, Robert L Owens, David McSharry, Jessie P Bakker, Atul Malhotra.   

Abstract

Untreated chronic obstructive pulmonary disease (COPD) co-existing with obstructive sleep apnea (OSA), also known as overlap syndrome, has higher cardiovascular mortality than COPD alone but its underlying mechanism remains unclear. We hypothesize that the presence of overlap syndrome is associated with more extensive right ventricular (RV) remodeling compared to patients with COPD alone. Adult COPD patients (GOLD stage 2 or higher) with at least 10 pack-years of smoking history were included. Overnight laboratory-based polysomnography was performed to test for OSA. Subjects with an apnea-hypopnea index (AHI) >10/h were classified as having overlap syndrome (n = 7), else classified as having COPD-only (n = 11). A cardiac MRI was performed to assess right and left cardiac chambers sizes, ventricular masses, and cine function. RV mass index (RVMI) was markedly higher in the overlap group than the COPD-only group (19 ± 6 versus 11 ± 6; p = 0.02). Overlap syndrome subjects had a reduced RV remodeling index (defined as the ratio between RVMI and RV end-diastolic volume index) compared to the COPD-only group (0.27 ± 0.06 versus 0.18 ± 0.08; p = 0.02). In the overlap syndrome subjects, the extent of RV remodeling was associated with severity of oxygen desaturation (R(2) = 0.65, p = 0.03). Our pilot results suggest that untreated overlap syndrome may cause more extensive RV remodeling than COPD alone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23272670      PMCID: PMC3679499          DOI: 10.3109/15412555.2012.719050

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  27 in total

1.  Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease.

Authors:  D Sajkov; T Wang; N A Saunders; A J Bune; A M Neill; R Douglas Mcevoy
Journal:  Am J Respir Crit Care Med       Date:  1999-05       Impact factor: 21.405

2.  The clinical diagnosis of pulmonary emphysema; an experimental study.

Authors:  C M FLETCHER
Journal:  Proc R Soc Med       Date:  1952-09

3.  PFT interpretive strategies: American Thoracic Society/ European Respiratory Society 2005 guideline gaps.

Authors:  Albert Miller; Paul L Enright
Journal:  Respir Care       Date:  2012-01       Impact factor: 2.258

4.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

5.  Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension.

Authors:  Roald J Roeleveld; Anton Vonk-Noordegraaf; J Tim Marcus; Jean G F Bronzwaer; Koen M J Marques; Pieter E Postmus; Anco Boonstra
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

6.  Sleep in chronic obstructive lung disease.

Authors:  D C Flenley
Journal:  Clin Chest Med       Date:  1985-12       Impact factor: 2.878

7.  Association of chronic obstructive pulmonary disease and sleep apnea syndrome.

Authors:  A Chaouat; E Weitzenblum; J Krieger; T Ifoundza; M Oswald; R Kessler
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

8.  Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease.

Authors:  E C Fletcher; J W Schaaf; J Miller; J G Fletcher
Journal:  Am Rev Respir Dis       Date:  1987-03

9.  Evaluation of right ventricular volumes measured by magnetic resonance imaging.

Authors:  J Møgelvang; M Stubgaard; C Thomsen; O Henriksen
Journal:  Eur Heart J       Date:  1988-05       Impact factor: 29.983

10.  Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease.

Authors:  Mark H Sanders; Anne B Newman; Catherine L Haggerty; Susan Redline; Michael Lebowitz; Jonathan Samet; George T O'Connor; Naresh M Punjabi; Eyal Shahar
Journal:  Am J Respir Crit Care Med       Date:  2003-01-01       Impact factor: 21.405

View more
  26 in total

1.  Poor Outcomes Among Patients With Chronic Obstructive Pulmonary Disease With Higher Risk for Undiagnosed Obstructive Sleep Apnea in the LOTT Cohort.

Authors:  Lucas M Donovan; Laura C Feemster; Edmunds M Udris; Matthew F Griffith; Laura J Spece; Brian N Palen; Ken He; Sairam Parthasarathy; Kingman P Strohl; Vishesh K Kapur; David H Au
Journal:  J Clin Sleep Med       Date:  2019-01-15       Impact factor: 4.062

2.  Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease.

Authors:  J Michael Wells; Anand S Iyer; Farbod N Rahaghi; Surya P Bhatt; Himanshu Gupta; Thomas S Denney; Steven G Lloyd; Louis J Dell'Italia; Hrudaya Nath; Raul San Jose Estepar; George R Washko; Mark T Dransfield
Journal:  Circ Cardiovasc Imaging       Date:  2015-04       Impact factor: 7.792

3.  The role of compact polysomnography/polygraphy in sleep breathing disorder patients' management.

Authors:  Marcello Bosi; Andrea De Vito; Claudio Vicini; Venerino Poletti
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-14       Impact factor: 2.503

4.  T1 measurements for detection of expansion of the myocardial extracellular volume in chronic obstructive pulmonary disease.

Authors:  Tomas G Neilan; Jessie P Bakker; Bhavneesh Sharma; Robert L Owens; Hoshang Farhad; Ravi V Shah; Siddique A Abbasi; Puja Kohli; Joel Wilson; Anthony DeMaria; Michael Jerosch-Herold; Raymond Y Kwong; Atul Malhotra
Journal:  Can J Cardiol       Date:  2014-08-19       Impact factor: 5.223

Review 5.  On the cutting edge of obstructive sleep apnoea: where next?

Authors:  Atul Malhotra; Jeremy E Orr; Robert L Owens
Journal:  Lancet Respir Med       Date:  2015-04-14       Impact factor: 30.700

Review 6.  Comorbid obstructive sleep apnoea and chronic obstructive pulmonary disease and the risk of cardiovascular disease.

Authors:  Walter T McNicholas
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 7.  Research Priorities in Pathophysiology for Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Research Statement.

Authors:  Atul Malhotra; Alan R Schwartz; Hartmut Schneider; Robert L Owens; Pamela DeYoung; MeiLan K Han; Jadwiga A Wedzicha; Nadia N Hansel; Michelle R Zeidler; Kevin C Wilson; M Safwan Badr
Journal:  Am J Respir Crit Care Med       Date:  2018-02-01       Impact factor: 21.405

Review 8.  Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Authors:  Nirupama Putcha; M Bradley Drummond; Robert A Wise; Nadia N Hansel
Journal:  Semin Respir Crit Care Med       Date:  2015-08-03       Impact factor: 3.119

9.  Physical Activity in Overlap Syndrome of COPD and Obstructive Sleep Apnea: Relationship With Markers of Systemic Inflammation.

Authors:  Christine M Fitzgibbons; Rebekah L Goldstein; Daniel J Gottlieb; Marilyn L Moy
Journal:  J Clin Sleep Med       Date:  2019-07-15       Impact factor: 4.062

10.  Pulmonary Overlap Syndromes, with a focus on COPD and ILD.

Authors:  Katherine A Dudley; Atul Malhotra; Robert L Owens
Journal:  Sleep Med Clin       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.